Biotech entity
fda-approval is the sole category represented across all 1 tracked stories. Bayer AG is most often covered alongside John L. Durnell, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Bayer AG appears in 1 tracked Biotech story from June 30, 2026.
Last mentioned: Jun 30, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
fda-approval is the sole category represented across all 1 tracked stories. Bayer AG is most often covered alongside John L. Durnell, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Bayer AG appears in 1 tracked Biotech story from June 30, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 1 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Bayer AG. Shared-story counts are live from our verified record — not editorial picks.
The U.S. Supreme Court ruled that FIFRA preempts state failure-to-warn claims against Bayer's Roundup, eliminating a massive source of litigation uncertainty. The 7-2 decision validates EPA's safety assessment of glyphosate and sharply reduces Bayer's outstanding tort exposure, potentially freeing up billions in capital for the biotech giant.
Source: National Law Review · National Law Review
Bayer AG is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
